Literature DB >> 35392358

Bioinformatics Method Was Used to Analyze the Highly Expressed Gene FAM83A of Breast Cancer in Young Women.

Yongzhe Tang1,2, Hao Wang3, Qi He1,2, Yuanyuan Chen1,2, Jie Wang1,2.   

Abstract

Objectives: Preliminary analysis of breast cancer related to unknown functional gene FAM83A through bioinformatics knowledge to inform further experimental studies. Select high expression genes for breast cancer and use bioinformatics methods to predict the biological function of FAM83A.
Methods: Genes with significant differences in expression between breast tumors and normal breast tissue libraries were selected from CGAP's SAGE Digital Gene Expression Displayer (DGED) database. An unknown functional gene, FAM83A, which is highly expressed in breast cancer, was screened. We performed an analysis of the gene structure, subcellular localization, physicochemical properties of the encoding products, functional sites, protein structure, and functional domains.
Results: Through SAGE DGED, a total of 185 genes with expression differences were found. The structure and function of FAM83A have ideal predictions, and it is generally determined that this gene encodes a nuclear protein with a nucleoprotein. The active site of PLDc and the functional domain of DUF1669 can be involved in signal transduction and gene expression regulation in tumorigenesis and metastasis. Digital gene representation of the Tumor Genome Project Data Library was used to select differentially expressed genes in breast cancer tissue and breast benign tumor tissue.
Conclusion: Studies show that FAM83A is a potential research target associated with tumorigenesis and metastasis. Initial tests confirmed the expression of this gene. Lay a solid foundation for further research learning. FAM83A is a highly expressed gene in breast cancer and can serve as a target for studying molecular mechanisms in breast cancer.
Copyright © 2022 Yongzhe Tang et al.

Entities:  

Year:  2022        PMID: 35392358      PMCID: PMC8983250          DOI: 10.1155/2022/5358030

Source DB:  PubMed          Journal:  Appl Bionics Biomech        ISSN: 1176-2322            Impact factor:   1.781


  50 in total

1.  Prevalence and Spectrum of Pathogenic Germline Variants in Japanese Patients With Early-Onset Colorectal, Breast, and Prostate Cancer.

Authors:  Xiaoxi Liu; Sadaaki Takata; Kyota Ashikawa; Tomomi Aoi; Shunichi Kosugi; Chikashi Terao; Nicholas F Parrish; Koichi Matsuda; Hidewaki Nakagawa; Yoichiro Kamatani; Michiaki Kubo; Yukihide Momozawa
Journal:  JCO Precis Oncol       Date:  2020-11

2.  The Association between Consumption of Dairy-Originated Digestion Resistant and Bioactive Peptides and Breast Cancer Risk: A Case-Control Study.

Authors:  Masoumeh Jabbari; Meisam Barati; Mahdi Shabani; Elham Kazemian; Sajad Khalili-Moghadam; Fardin Javanmardi; Elaheh Hatami; Reihaneh Zeinalian; Sayed Hossein Davoodi; Bahram Rashidkhani; Shima Jafarzadeh; Elcin Huseyn; Amin Mousavi Khaneghah
Journal:  Nutr Cancer       Date:  2022-01-20       Impact factor: 2.816

3.  Evaluation of the Value of Multiplex MicroRNA Analysis as a Breast Cancer Screening in Korean Women under 50 Years of Age with a High Proportion of Dense Breasts.

Authors:  Ji Young Jang; Eun Young Ko; Ji Soo Jung; Kyung Nam Kang; Yeon Soo Kim; Chul Woo Kim
Journal:  J Cancer Prev       Date:  2021-12-30

4.  Correction for: Silencing DSCAM-AS1 suppresses the growth and invasion of ER-positive breast cancer cells by downregulating both DCTPP1 and QPRT.

Authors:  Zhang Yue; Jia Shusheng; Song Hongtao; Zhao Shu; Huang Lan; Zhang Qingyuan; Cheng Shaoqiang; Huang Yuanxi
Journal:  Aging (Albany NY)       Date:  2022-01-15       Impact factor: 5.682

5.  Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer.

Authors:  Yingrong Shi; Si Chen; Huijuan Xing; Guanglie Jiang; Nan Wu; Qiannan Liu; Norihiro Sakamoto; Takayoshi Kuno; Reiko Sugiura; Qinghuan Xiao; Feng Jin; Yue Fang; Fan Yao
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

6.  Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status.

Authors:  Marie-France Savard; Elizabeth N Kornaga; Adriana Matutino Kahn; Sasha Lupichuk
Journal:  Curr Oncol       Date:  2022-01-16       Impact factor: 3.677

7.  Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer.

Authors:  Xueying Wu; Chenyang Zhang; Henghui Zhang
Journal:  Curr Oncol       Date:  2022-01-10       Impact factor: 3.677

8.  Multimodal Imaging of Target Detection Algorithm under Artificial Intelligence in the Diagnosis of Early Breast Cancer.

Authors:  Meiping Jiang; Sanlin Lei; Junhui Zhang; Liqiong Hou; Meixiang Zhang; Yingchun Luo
Journal:  J Healthc Eng       Date:  2022-01-10       Impact factor: 2.682

9.  Fatty acid synthetase expression in triple-negative breast cancer.

Authors:  Jin Hee Park; Hye Seung Han; So Dug Lim; Wook Youn Kim; Kyoung Sik Park; Young Bum Yoo; Seung Eun Lee; Wan-Seop Kim
Journal:  J Pathol Transl Med       Date:  2022-01-21

10.  Same-day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer.

Authors:  Anselm Tamminen; Tuomo Meretoja; Ilkka Koskivuo
Journal:  J Surg Oncol       Date:  2022-01-20       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.